These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 38086389)
1. APOE3ch alters microglial response and suppresses Aβ-induced tau seeding and spread. Chen Y; Song S; Parhizkar S; Lord J; Zhu Y; Strickland MR; Wang C; Park J; Tabor GT; Jiang H; Li K; Davis AA; Yuede CM; Colonna M; Ulrich JD; Holtzman DM Cell; 2024 Jan; 187(2):428-445.e20. PubMed ID: 38086389 [TBL] [Abstract][Full Text] [Related]
2. Activated microglia mitigate Aβ-associated tau seeding and spreading. Gratuze M; Chen Y; Parhizkar S; Jain N; Strickland MR; Serrano JR; Colonna M; Ulrich JD; Holtzman DM J Exp Med; 2021 Aug; 218(8):. PubMed ID: 34100905 [TBL] [Abstract][Full Text] [Related]
3. Selective reduction of astrocyte apoE3 and apoE4 strongly reduces Aβ accumulation and plaque-related pathology in a mouse model of amyloidosis. Mahan TE; Wang C; Bao X; Choudhury A; Ulrich JD; Holtzman DM Mol Neurodegener; 2022 Feb; 17(1):13. PubMed ID: 35109920 [TBL] [Abstract][Full Text] [Related]
4. APOE Antibody Inhibits Aβ-Associated Tau Seeding and Spreading in a Mouse Model. Gratuze M; Jiang H; Wang C; Xiong M; Bao X; Holtzman DM Ann Neurol; 2022 Jun; 91(6):847-852. PubMed ID: 35285073 [TBL] [Abstract][Full Text] [Related]
6. Distinct tau neuropathology and cellular profiles of an APOE3 Christchurch homozygote protected against autosomal dominant Alzheimer's dementia. Sepulveda-Falla D; Sanchez JS; Almeida MC; Boassa D; Acosta-Uribe J; Vila-Castelar C; Ramirez-Gomez L; Baena A; Aguillon D; Villalba-Moreno ND; Littau JL; Villegas A; Beach TG; White CL; Ellisman M; Krasemann S; Glatzel M; Johnson KA; Sperling RA; Reiman EM; Arboleda-Velasquez JF; Kosik KS; Lopera F; Quiroz YT Acta Neuropathol; 2022 Sep; 144(3):589-601. PubMed ID: 35838824 [TBL] [Abstract][Full Text] [Related]
7. Aβ-induced acceleration of Alzheimer-related τ-pathology spreading and its association with prion protein. Gomes LA; Hipp SA; Rijal Upadhaya A; Balakrishnan K; Ospitalieri S; Koper MJ; Largo-Barrientos P; Uytterhoeven V; Reichwald J; Rabe S; Vandenberghe R; von Arnim CAF; Tousseyn T; Feederle R; Giudici C; Willem M; Staufenbiel M; Thal DR Acta Neuropathol; 2019 Dec; 138(6):913-941. PubMed ID: 31414210 [TBL] [Abstract][Full Text] [Related]
8. Opposing effects of progranulin deficiency on amyloid and tau pathologies via microglial TYROBP network. Takahashi H; Klein ZA; Bhagat SM; Kaufman AC; Kostylev MA; Ikezu T; Strittmatter SM; Acta Neuropathol; 2017 May; 133(5):785-807. PubMed ID: 28070672 [TBL] [Abstract][Full Text] [Related]
9. Metformin attenuates plaque-associated tau pathology and reduces amyloid-β burden in APP/PS1 mice. Chen Y; Zhao S; Fan Z; Li Z; Zhu Y; Shen T; Li K; Yan Y; Tian J; Liu Z; Zhang B Alzheimers Res Ther; 2021 Feb; 13(1):40. PubMed ID: 33563332 [TBL] [Abstract][Full Text] [Related]
10. Anti-Aβ antibodies bound to neuritic plaques enhance microglia activity and mitigate tau pathology. Laversenne V; Nazeeruddin S; Källstig EC; Colin P; Voize C; Schneider BL Acta Neuropathol Commun; 2020 Nov; 8(1):198. PubMed ID: 33225991 [TBL] [Abstract][Full Text] [Related]
11. Human tau increases amyloid β plaque size but not amyloid β-mediated synapse loss in a novel mouse model of Alzheimer's disease. Jackson RJ; Rudinskiy N; Herrmann AG; Croft S; Kim JM; Petrova V; Ramos-Rodriguez JJ; Pitstick R; Wegmann S; Garcia-Alloza M; Carlson GA; Hyman BT; Spires-Jones TL Eur J Neurosci; 2016 Dec; 44(12):3056-3066. PubMed ID: 27748574 [TBL] [Abstract][Full Text] [Related]
12. Effects of CX3CR1 and Fractalkine Chemokines in Amyloid Beta Clearance and p-Tau Accumulation in Alzheimer's Disease (AD) Rodent Models: Is Fractalkine a Systemic Biomarker for AD? Merino JJ; Muñetón-Gómez V; Alvárez MI; Toledano-Díaz A Curr Alzheimer Res; 2016; 13(4):403-12. PubMed ID: 26567742 [TBL] [Abstract][Full Text] [Related]
16. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models. Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S Elife; 2020 Jun; 9():. PubMed ID: 32510331 [TBL] [Abstract][Full Text] [Related]
17. Human apolipoprotein E redistributes fibrillar amyloid deposition in Tg-SwDI mice. Xu F; Vitek MP; Colton CA; Previti ML; Gharkholonarehe N; Davis J; Van Nostrand WE J Neurosci; 2008 May; 28(20):5312-20. PubMed ID: 18480287 [TBL] [Abstract][Full Text] [Related]
18. Microglia contributes to plaque growth by cell death due to uptake of amyloid β in the brain of Alzheimer's disease mouse model. Baik SH; Kang S; Son SM; Mook-Jung I Glia; 2016 Dec; 64(12):2274-2290. PubMed ID: 27658617 [TBL] [Abstract][Full Text] [Related]
19. The role of microglia in processing and spreading of bioactive tau seeds in Alzheimer's disease. Hopp SC; Lin Y; Oakley D; Roe AD; DeVos SL; Hanlon D; Hyman BT J Neuroinflammation; 2018 Sep; 15(1):269. PubMed ID: 30227881 [TBL] [Abstract][Full Text] [Related]
20. Genetically augmenting tau levels does not modulate the onset or progression of Abeta pathology in transgenic mice. Oddo S; Caccamo A; Cheng D; Jouleh B; Torp R; LaFerla FM J Neurochem; 2007 Aug; 102(4):1053-63. PubMed ID: 17472708 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]